Melanoma-associated antigen 3 (MAGE-A3), a CTA highly expressed in NSCLC 11, 12, is intracellularly processed with human leukocyte antigens (HLAs) on the cell surface, therefore, was utilized as an important therapeutic target in NSCLC. Here, HLA-S is linked to non-small cell lung carcinoma.